US20040052925A1 - Soybean milks containing epa at high concentration and process for producing the same - Google Patents
Soybean milks containing epa at high concentration and process for producing the same Download PDFInfo
- Publication number
- US20040052925A1 US20040052925A1 US10/416,020 US41602003A US2004052925A1 US 20040052925 A1 US20040052925 A1 US 20040052925A1 US 41602003 A US41602003 A US 41602003A US 2004052925 A1 US2004052925 A1 US 2004052925A1
- Authority
- US
- United States
- Prior art keywords
- soybean milk
- fish oil
- epa
- soybean
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 244000068988 Glycine max Species 0.000 title claims abstract description 409
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 409
- 235000013336 milk Nutrition 0.000 title claims abstract description 373
- 210000004080 milk Anatomy 0.000 title claims abstract description 373
- 238000000034 method Methods 0.000 title claims description 22
- 230000008569 process Effects 0.000 title description 8
- 239000008267 milk Substances 0.000 claims abstract description 372
- 235000021323 fish oil Nutrition 0.000 claims abstract description 159
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 57
- 201000005577 familial hyperlipidemia Diseases 0.000 claims abstract description 52
- 235000013305 food Nutrition 0.000 claims abstract description 52
- 235000013361 beverage Nutrition 0.000 claims abstract description 34
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 33
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 33
- 235000013527 bean curd Nutrition 0.000 claims abstract description 32
- 239000007787 solid Substances 0.000 claims abstract description 28
- 235000013376 functional food Nutrition 0.000 claims abstract description 23
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 125000004494 ethyl ester group Chemical group 0.000 claims abstract description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 94
- 235000012000 cholesterol Nutrition 0.000 claims description 45
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 230000003078 antioxidant effect Effects 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- 229960001295 tocopherol Drugs 0.000 claims description 9
- 229930003799 tocopherol Natural products 0.000 claims description 9
- 235000010384 tocopherol Nutrition 0.000 claims description 9
- 239000011732 tocopherol Substances 0.000 claims description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 9
- 230000000050 nutritive effect Effects 0.000 abstract description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 127
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 127
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 127
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 127
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 118
- 239000000047 product Substances 0.000 description 64
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 61
- 229940090949 docosahexaenoic acid Drugs 0.000 description 59
- 241000894006 Bacteria Species 0.000 description 24
- 238000004945 emulsification Methods 0.000 description 22
- 238000000855 fermentation Methods 0.000 description 18
- 230000004151 fermentation Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 235000019640 taste Nutrition 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 241000251468 Actinopterygii Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 235000019688 fish Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000001766 physiological effect Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 235000013618 yogurt Nutrition 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241001125048 Sardina Species 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 239000000701 coagulant Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 229940013317 fish oils Drugs 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 235000021085 polyunsaturated fats Nutrition 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- 241000736029 Ruvettus pretiosus Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004332 deodorization Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 235000019512 sardine Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 2
- MBDOYVRWFFCFHM-UHFFFAOYSA-N 2-hexenal Chemical compound CCCC=CC=O MBDOYVRWFFCFHM-UHFFFAOYSA-N 0.000 description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241001131796 Botaurus stellaris Species 0.000 description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 235000020805 dietary restrictions Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 description 2
- 229960003681 gluconolactone Drugs 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- MBDOYVRWFFCFHM-SNAWJCMRSA-N 2-Hexenal Natural products CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000276694 Carangidae Species 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
- A23C11/106—Addition of, or treatment with, microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C20/00—Cheese substitutes
- A23C20/02—Cheese substitutes containing neither milk components, nor caseinate, nor lactose, as sources of fats, proteins or carbohydrates
- A23C20/025—Cheese substitutes containing neither milk components, nor caseinate, nor lactose, as sources of fats, proteins or carbohydrates mainly containing proteins from pulses or oilseeds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/40—Pulse curds
- A23L11/45—Soy bean curds, e.g. tofu
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
- A23L11/65—Soy drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a soybean milk product containing EPA at a high content, and more particularly to a soybean milk product, which is effective to hyperlipemia and has a high nutritive value, and a method of producing the soybean milk product.
- Soybean milk is employed not only as materials of Tofu (bean curd), but also as beverages that are directly taken by people as functional foods in recent years.
- the soybean milk is usually produced as follows. First, soybeans are washed with water for removal of dust and so on. Then, the soybeans are soaked in water at the normal temperature of volume three times as much as the soybeans, and are held in the soaked condition for 5 to 20 hours depending on the season. During such a period, imbibition and germination of the soybeans occurs. Then, the imbibed soybeans are put in a grinding device, such as a mixer and a mortar, and are ground at the normal temperature while water at the normal temperature is added in volume about 5 to 6 times as much as the soybeans.
- a grinding device such as a mixer and a mortar
- Raw soybean juice (or soybean juice) is thereby produced. After heating the raw soybean juice for about 3 to 15 minutes, it is subjected to a solid-liquid separation process at high temperatures using a solid-liquid separation device, such as a centrifugal separator and a filter press. As a result, soybean milk and bean curd lees are obtained.
- a solid-liquid separation device such as a centrifugal separator and a filter press.
- the soybean milk thus produced is provided as Tofu after being added with a coagulant, e.g., bittern, gluconolactone and calcium sulfate, or as beverages after being directly packed in a container and then sealed off.
- a coagulant e.g., bittern, gluconolactone and calcium sulfate
- beverages containing soybean milk have unpleasant tastes, such as green grass smell and a bitter taste, due to the presence of small amounts of ill-smelling components including 2-hexenal and several kinds of saponins, and those unpleasant tastes have hitherto invited the biggest difficulty in utilization of the soybean milk.
- Various proposals on lactic bacteria fermentation using lactic bacteria have been made for a taste improvement of the soybean milk. But those proposals for masking the unpleasant odor of a soy bean cancel a body taste and Umami (savory taste) specific to the soy bean. Therefore, the problem of the unpleasant odor and taste specific to the soy bean is not yet overcome at the present.
- soybean protein has an effect of reducing cholesterol. That fact has increased the number of people eating Tofu recently.
- containers, sauces and spices are required when eating Tofu, and places where people can eat Tofu are limited.
- beverages containing soybean milk are packed in containers and sealed off in a portable way, there are no limitations on places for people to drink the packed beverages and people can easily take in the soybean milk as functional foods anywhere.
- EPA and DHA are typical ones of polyunsaturated fatty acids and are relatively abundantly contained in fat of fish (referred to as a “fish oil” hereinafter), such as fatty meat of a horse mackerei, salmon roe, yellow tail, mackerei, saury, eel, pilchard, rainbow trout, salmon, and saurel.
- fish oil a fat of fish
- physiological activity effects such as a platelet aggregation inhibitory effect, a blood triglyceride lowering effect, and a blood VLDL and LDL cholesterol lowering effect, and hence have preventive and remedial effects for arteriosclerotic diseases. It is also known that depletion of DHA lowers the memory learning ability.
- Japanese Patent Laid-Open Publication No. 7-255406 discloses a method of producing soy bean processed food enriched with polyunsaturated fat, wherein soybean milk containing polyunsaturated fat is produced by mixing soybean milk and about 1% to about 25% of polyunsaturated fat with respect to the weight of soybean protein in the soybean milk.
- a maximum amount of EPA(DHA)-containing liquid fat uniformly dispersible in 18 liters of soybean milk is 160 g (about 25% with respect to the weight of protein in the soybean milk)”, and “if the fat content exceeds about 25%, the fat is not uniformly dispersed and an oil component is separated”.
- Japanese Patent Laid-Open Publication No. 10-42819 discloses “a method of producing a beverage containing DHA-mixed soybean milk, the method comprising the steps of adding and mixing soybean milk and a DHA-containing fish oil at a weight ratio of 1:0.2 to 1, thereby preparing an emulsion of the DHA-containing fish oil, and further diluting the emulsion with the soybean milk”.
- An object of the present invention is to provide a soybean milk product containing fish-oil-originated EPA and/or DHA at a high content, and more particularly to a soybean milk product, which is effective to hyperlipemia and has a high nutritive value, and a method of producing the soybean milk product.
- the required amount of EPA is 750 mg/day in terms of EPA-TG and 1800 mg/day in terms of ethyl ester as a medicine.
- the above-cited Japanese Patent Laid-Open Publication No. 7-255406 does not disclose the kind of polyunsaturated fat used for producing the soybean milk, the content of EPA and DHA mixed in foods is usually about 25% at maximum. Based on such a value, the EPA content in the soybean milk is calculated as about 0.2%. It is hence cannot be said that the EPA content in the soybean milk satisfies the intake per day sufficiently.
- a maximum limit in addition of EPA in the prior art is about 280 mg/100 ml on condition that the content of soybean protein in the solid part is about 50%.
- the present invention is intended to enable the soybean milk to contain EPA in a larger amount than that maximum limit.
- soybean protein is effective in suppressing a high cholesterol condition and EPA is effective in suppressing a high triglyceride condition.
- EPA is effective in suppressing a high triglyceride condition.
- the effectiveness, the ease in use, etc. of the functional foods greatly depend on in what form and amount EPA is mixed because EPA is easily oxidized and has a foul odor, and in what amount the soybean protein is required.
- the present invention is intended to realize a soybean milk product containing soybean protein and EPA at required contents in the soybean milk of not more than 200 ml or not more than 125 ml. Further, the present invention is intended to provide a soybean milk product, to be taken in as functional foods having a superior nutritive value, wherein an appropriate amount of purified fish oil containing EPA is dispersed and dissolved in the soybean milk.
- the present invention is intended to provide a soybean milk product that is expected to develop physiological activities of DHA contained therein together with EPA.
- the above object and intensions are achieved by providing a soybean milk product wherein triglyceride or ethyl ester containing 10% or more of EPA is mixed in amount of more than 25% of the soybean protein in the soybean milk.
- the present invention resides in a soybean milk product wherein triglyceride or ethyl ester containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of soybean solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the triglyceride is a fish oil.
- the present invention resides in a soybean milk product wherein a fish oil containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil contains EPA and/or DHA in adjusted amount.
- the present invention resides in a soybean milk product wherein a fish oil containing 10% or more of EPA, or preferably a fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil is a purified fish oil.
- the present invention resides in a soybean milk product wherein a purified fish oil containing 10% or more of EPA, or preferably a purified fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil contains EPA and DHA in total amount of 25% or more.
- the present invention resides in a soybean milk product wherein a fish oil (preferably purified fish oil) containing 10% or more of EPA and containing EPA and DHA in total amount of 25% or more, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil contains 28% or more of EPA.
- the present invention resides in a soybean milk product wherein a fish oil (preferably purified fish oil) containing 28% or more of EPA, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil is a fish oil added with 0.5% or more of tocopherol as an antioxidant.
- the present invention resides in a soybean milk product wherein a fish oil containing 10% or more of EPA, preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, each of the fish oils or the purified fish oils being added with 0.5% or more of tocopherol as an antioxidant, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being
- the soybean milk product is produced by preparing a soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk.
- the present invention resides in a soybean milk product wherein the soybean milk product is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk, the fish oil being a fish oil containing 10% or more of EPA, or a fish oil or a purified fish oil added, as required, with 0.5% or more of tocopherol as an antioxidant, being preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, being more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or being even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, the fish oil being mixed in the soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein triglyceride or ethyl ester containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the triglyceride is a fish oil.
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, in which a fish oil containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil contains EPA and/or DHA in adjusted amount.
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil containing 10% or more of EPA, or preferably a fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil is a purified fish oil.
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a purified fish oil containing 10% or more of EPA, or preferably a purified fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- the fish oil contains EPA and DHA in total amount of 25% or more.
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil (preferably purified fish oil) containing 10% or more of EPA and containing EPA and DHA in total amount of 25% or more, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases
- the fish oil contains 28% or more of EPA.
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil (preferably purified fish oil) containing 28% or more of EPA, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- a fish oil preferably purified fish oil
- EPA
- the fish oil is a fish oil added with 0.5% or more of tocopherol as an antioxidant.
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil containing 10% or more of EPA, preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, each of the fish oils or the purified fish oils being added with 0.5% or more of tocopherol as an antioxidant, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk,
- the soybean milk product is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk.
- the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein the soybean milk is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk, the fish oil being a fish oil containing 10% or more of EPA, or a fish oil or a purified fish oil added, as required, with 0.5% or more of tocopherol as an antioxidant, being preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, being more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or being even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, the fish oil being mixed in soybean
- the present invention resides in a method of producing a soybean milk product, the method comprising the steps of preparing soybean milk through a series of steps, and then adding and mixing, in the prepared soybean milk, a fish oil containing 10% or more of EPA in amount of more than 25% of the soybean protein in the soybean milk.
- FIG. 1 is a graph showing a change of whole cholesterol over time resulting from a test in Example 6.
- FIG. 2 is a graph showing a change of triglyceride over time resulting from the test in Example 6.
- Soybean milk preferably soybean milk containing 3% or more of solid part, for use in the present invention may be obtained by any suitable method, and it can be, for example, soybean milk produced by a usual method from soybeans and/or defatted soybeans.
- soybean milk produced by a usual method from soybeans and/or defatted soybeans.
- skin- and albumen-removed soybeans are used in point of providing soybean milk with a better taste.
- the soybean milk thus produced is provided as a beverage containing the soybean milk as it is, or Tofu after being added with a coagulant, e.g., bittern, gluconolactone and calcium sulfate, or fermented soybean milk (acidified soybean milk) after being subjected to lactic bacteria fermentation.
- the soybean milk is any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk.
- Soybean milk can be produced by grinding whole soybeans and/or skin-removed soybeans, which are in a hydrated condition after or without being soaked in water, to obtain soybean juice, and then by removing insoluble fractions from the soybean juice through, e.g., filtration. More specifically, soybean milk is produced as follows. First, whole soybeans, skin-removed soybeans, and/or skin- and albumen-removed soybeans are contacted with warm or hot water at 50 to 100° C. to remove components which are soluble in the warm or hot water. Then, the imbibed soybeans are ground to obtain raw soybean juice (or soybean juice).
- soybean juice is immediately introduced to a solid-liquid separation device, such as a centrifugal separator, for quick separation into solid and liquid parts.
- a filtrate (soybean milk) obtained after removing an insoluble fraction (solid part called bean curd lees) is preferably used as the soybean milk in the present invention.
- an ordinary grinding device such as a mortar, a mixing machine and a mixer, can be used.
- the obtained soybean milk may be subjected to heat sterilization at 135 to 150° C. for 1 to 120 seconds, and then cooled.
- the soybean milk can be produced by a usual method from soybeans and/or defatted soybeans, but may preferably contain 1.0 weight % or less of soluble glucose in a dry material of the soybean milk for the purpose of facilitating control of the lactic bacteria fermentation and providing a product having a fine fresh taste free from unfavorable tastes.
- Lactic bacteria assimilation saccharides e.g., oligosaccharides
- Lactic bacteria for use in the lactic bacteria fermentation are not limited to particular ones, but may be strains usually employed in yogurt, or may be any of combinations of known strains used for improving the taste of the soybean milk.
- lactic bacteria belonging to such genuses as Lactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus casei, Streptococcus thermophilus, Streptococcus thermophilus, Streptococcus lactis, and Bifidobacterium, are usable. Those lactic bacteria can be used either alone or a combination of two or more selected from among them.
- a fermentation method can be implemented by adding a bulk starter prepared in advance, or by adding frozen concentrated bacteria or freeze-dry concentrated bacteria directly in the soybean milk.
- the amount of added bulk start is, e.g., 0.5 to 15%, and in the case of directly adding lactic bacteria, the amount of the added lactic bacteria is selected so that the onset bacteria density is, e.g., not less than 10 5 /ml.
- the lactic bacteria fermentation can be performed at the fermentation temperature of 20 to 50° C. for 3 to 48 hours and preferably 25 to 45° C. for 4 to 24 hours.
- a fermentation device may be a similar one as that usually employed for producing fermented milk using milk as materials.
- a soybean milk product containing EPA which is intended by the present invention, is obtained by mixing, in soybean milk which is the filtrate (soybean milk) containing 3% or more of solid part and, or is acidified soybean milk produced from the filtrate through the lactic bacteria fermentation, or is Tofu obtained by curding the filtrate with addition of a coagulant, an EPA-containing purified fish oil in amount of more than 25% of the soybean protein in the soybean milk.
- a purified fish oil which is to be mixed in the filtrate (soybean milk), or acidified soybean milk produced from the filtrate through the lactic bacteria fermentation, or Tofu obtained by curding the filtrate with addition of a coagulant, is preferably concentrated to such an extent that the content of EPA and/or DHA exceeds 25%.
- the soybean milk produced through the lactic bacteria fermentation, to which the fat has been added can be provided as fermented soybean milk of soft yogurt type by packing the produced soybean milk, as it is, in a container after the steps of mixing and cooling, or as fermented soybean milk of drink yogurt type by cooling the produced soybean milk after the step of homogenization.
- various fruit types of soybean milk products can be produced by adding, as required, various flavors, pigments, stabilizers, and fruit preparations.
- the soybean milk produced through the lactic bacteria fermentation which has been packed in a small container and then fermented, can be provided as lactic-bacteria fermented soybean milk of hard yogurt type by cooling it such a packed condition.
- various flavors, pigments, stabilizers, etc. can be freely added to the soybean milk prior to the start of the fermentation.
- the triglyceride for use in the present invention can be given as, e.g., a fish oil and microbe-origin fat
- the ethyl ester for use in the present invention can be given as, e.g., one obtained through ethyl esterification of microbe-origin fat. Origins of the triglyceride and ethyl ester are not matters of problem so long as they can be used as foods.
- the fish oil for use in the present invention is a fish oil containing 10% or more of EPA, preferably a fish oil containing EPA and DHA in total amount of 25% or more, and more preferably a fish oil containing 28% or more of EPA. Also, the fish oil is given as a fish oil or a purified fish containing EPA and/or DHA in adjusted amount. The fish oil may be added with 0.5% or more of tocopherol as an antioxidant.
- the purified fish oil is produced through a first purification process (degumming ⁇ refining with alkali ⁇ bleaching ⁇ filtration) in which a fish oil from raw material fish, such as sardine, is processed to obtain a raw fish oil, and a second purification process (adsorption ⁇ distillation ⁇ deodorization ⁇ addition of antioxidant) in which the raw fish oil is processed into the purified fish oil.
- a first purification process degumming ⁇ refining with alkali ⁇ bleaching ⁇ filtration
- a second purification process adsorption ⁇ distillation ⁇ deodorization ⁇ addition of antioxidant
- the purified fish oil is mixed in the soybean milk in amount of more than 25% of the soybean protein in the soybean milk so that the guideline of intake of EPA per day, i.e., 750 mg/day, is achieved.
- a maximum limit in amount of the soybean milk capable of being taken in by people per day is about 200 ml, and that the intake of EPA per day is not less than 900 mg in terms of fatty acid glyceride
- the present invention provides a soybean milk product containing soybean protein and EPA at required contents in the soybean milk of not more than 200 ml or not more than 125 ml.
- the present invention provide a soybean milk product, to be taken in as functional foods having a superior nutritive value, wherein an appropriate amount of purified fish oil containing EPA is dispersed and dissolved in the soybean milk. Although details of the metabolism occurred in the living body are not yet fully clarified, the physiological activities of DHA, which is present in the fish oil along with EPA, can also be expected. From this point of view, a fish oil containing EPA and DHA in total amount of 25% or more is preferably used.
- the soybean milk product is produced by preparing soybean milk through a series of steps, degassing the prepared soybean milk, and then mixing a fish oil in it.
- the emulsification is carried out under an atmosphere replaced by nitrogen, or using a mixing device of the type not allowing the soybean milk to take in air.
- the emulsification is preferably performed in two stages. Following the first stage of rough emulsification, the second stage of fine emulsification is performed immediately without a time lag.
- the soybean milk containing the fish oil is subjected to heat sterilization and packed in a container with a packing machine.
- the soybean milk product of the present invention implies various types of products made of soybean milk as a main material.
- the soybean milk includes, for example, raw soybean milk, adjusted soybean milk obtained by processing raw soybean milk, beverages containing soybean milk, and fermented soybean milk obtained through lactic bacteria fermentation.
- a food product containing the soybean milk product of the present invention implies foods that are made of soybean milk so far, foods that can be partly replaced by soybean milk without problems, and foods to which soybean milk can be added without problems.
- the soybean milk product of the present invention in the process of producing those foods, the fish oil containing EPA can be easily mixed in the foods.
- the foods that can be partly replaced by soybean milk include, for example, milk, yogurt, lactic bacteria drinks, and margarine.
- the foods to which soybean milk can be added include, for example, breads, cakes, pastes, and sauces.
- oxidation resistance can be improved by carrying out the emulsification process which prevents the soybean milk from taking in oxygen. Also, by performing the two stages of emulsification, i.e., rough emulsification and fine emulsification, in succession without a time interval between them, emulsification stability can also be improved. Even in the case of using fermented soybean milk, that emulsification process enables the oil fish to be mixed in the soybean milk after being subjected to the fermentation without problems.
- functional foods containing EPA in an effective amount can be produced by mixing, in soybean milk containing 3% or more of solid part (including adjusted soybean milk, beverages containing soybean milk, acidified soybean, and Tofu obtained by curding soybean milk), an EPA-containing purified fish oil in amount of more than 25% of the soybean protein in the soybean milk.
- solid part including adjusted soybean milk, beverages containing soybean milk, acidified soybean, and Tofu obtained by curding soybean milk
- an EPA-containing purified fish oil in amount of more than 25% of the soybean protein in the soybean milk.
- a maximum limit of the added EPA is about 280 mg/100 ml in the prior art.
- the present invention makes it possible to add EPA to the soybean milk in amount higher than such a maximum limit, and to achieve the EPA intake of 750 mg/day that is the guideline of an EPA intake per day specified by JHNA (Japan Health Food & Nutrition Food Association).
- the present invention can provide, for example, a beverage effective to hyperlipemia, which contains EPA at a content of 900 mg/125 ml, and a sport drink containing EPA at a content of 900 mg/200 ml.
- the EPA intake per day recommended by JHNA is 750 mg/day. Additionally, the physiological activities of DHA, which is present in the fish oil along with EPA, can also be expected.
- Fat used in Examples is a purified fish oil made by Nippon Suisan Kaisha Ltd. and has physical properties shown in Table 1 given below.
- This purified fish oil is produced through a first purification process (degumming ⁇ refining with alkali ⁇ bleaching ⁇ filtration) in which a fish oil from raw material fish, such as sardine, is processed to obtain a raw fish oil), a wintering process of the raw fish oil, and a second purification process (adsorption ⁇ distillation ⁇ deodorization ⁇ addition of antioxidant) in which the raw fish oil is processed into the purified fish oil.
- soybean milk thus obtained was diluted with water so that the soybean milk contained 10% of soybean solid part.
- a fish oil containing EPA (EPA content of 28%) was mixed in 5 liter of the soybean milk so that the soybean milk contained 1.8% of the fish oil.
- the mixture was mixed using a homo-mixer and a homegenizer having specifications listed respectively in (1) and (2) below, whereby soybean milk containing EPA (EPA content of 0.5%) was obtained.
- Head diameter of 15 cm
- Maker Sanwa Machine K.K.
- Capacity 500 L/h (medium type)
- soybean milk prepared through the same steps as those in Example 1 was diluted with water so that the soybean milk contained 10% of soybean solid part.
- the mixture was mixed using the homo-mixer and the homegenizer, whereby soybean milk containing EPA (EPA content of 0.5%) was obtained.
- a soybean milk product thus produced was packed in a retort pack in a sterility condition, and then left stand at 40° C. for about 3 weeks. As a result of a sensuality test made on the product after that, any fish-origin odor did not occur and any problems were not found.
- a sweetener, a flavor, etc. are first added to water heated to 50-55° C., and the soybean milk was then added to the water. Thereafter, the purified fish oil was added to neutral soybean milk and acidified soybean milk at composition ratio listed in Table 2 given below. Respective resulting products were sealed off and preserved at the room temperature for three months.
- mice of 4-week age were divided into four groups (control, fish oil, soybean milk and examination groups) each including six rats.
- the rats in the control group were fed in a free state with feed and water, the feed being prepared by adding 3.6% of an olive oil to basic feed containing 0.5% of cholesterol and 0.25% of cholic acid of sodium.
- the rats in the fish oil group were fed in a free state with feed and water, the feed being prepared by adding 3.6% of a fish oil, which contained 28% of EPA and 12% of DHA, to the basic feed.
- the rats in the soybean milk group were fed in a free state with the same feed as that given to the control group and soybean milk.
- the rats in the examination group were fed in a free state with the same feed as that given to the control group and the soybean milk product of the present invention, which was prepared by adding 1.8% of a fish oil containing 28% of EPA and 12% of DHA to soybean milk. After two weeks, blood was drawn from the anesthetized heart of the rat in each group and measured for whole cholesterol, HDL cholesterol, and trigrylicride in plasma. Measured results are listed in Table 3 given below.
- a pre-test was conducted on the blood triglyceride lowering effect of the soybean milk product of the present invention based on a human test.
- the production process in this Example is featured in performing a pre-emulsification step prior to the emulsification step for the purpose of improving a level of emulsification and providing the product superior in emulsification stability.
- the production process comprises the steps of preparation of soybean milk ⁇ degassing ⁇ pre-emulsification ⁇ emulsification ⁇ sterilization ⁇ packing.
- the pre-emulsification was first performed to such an extent that the grain size of 60 to 70 ⁇ m was obtained, and the main emulsification was then performed to such an extent that the grain size of 1 to 5 ⁇ m was obtained.
- the term “grain size” mans the mean grain size measured using SALD-200VER made by Shimazu Seisakusho K.K.
- Table 4 triglyceride value (mg/dl) for “S” and “F” TABLE 4 Triglyceride Value (mg/dl) 0 week 2 weeks 4 weeks 6 weeks 8 weeks “S” 249 203 133 164 115 “F” 180 108 148 181 140
- a sample used was fermented soybean milk (one 125-ml bottle mixed with 900 mg of EPA and 350 mg of DHA) in which a purified fish oil containing eicosapentaenoic acid and docosahexaenoic acid (referred to as “EPA. DHA” hereinafter).
- the nutrient composition and material combination ratio of the used sample are listed in Tables 5 and 6 given below.
- the fermented soybean milk was a commercialized one made by Fuji Oil K.K.
- the purified fish oil containing EPA•DHA was a commercialized one made by Nippon Suisan KAISHA LTD.
- the serum whole cholesterol value was reduced from 231 ⁇ 31 mg/dl (mean ⁇ standard deviation, this similarly applied to values given below) at the time of starting to take in the beverage down to 211 ⁇ 36.4 mg/dl, i.e., 8.7%, after 12 weeks (FIG. 1). Also, the serum triglycride value was reduced from 236.8 ⁇ 88.2 mg/dl at the time of starting to take in the beverage down to 156.8 ⁇ 56.4 mg/dl, i.e., 33.8%, after 12 weeks (FIG. 2). During the test period, neither problematic side effects nor drop-out examples occurred.
- a soybean milk product containing EPA•DHA can be provided which does not cause a fish odor originating from a fish oil uses as materials, which is superior in taste, smell and texture, which shows good preservability of EPA•DHA, which and enables people to take in EPA•DHA together with soybean milk as a good protein source.
- a stable soybean milk product containing EPA•DHA at high contents can be provided with the production process in which, to prevent the soybean milk from taking in oxygen during the production process, the emulsification is carried out under an atmosphere replaced by nitrogen, or using a mixing device of the type not allowing the soybean milk to take in air, and in which the second stage of fine emulsification is performed immediately after the first stage of rough emulsification.
Abstract
The invention provides a soybean milk product, which contains fish-oil-originated EPA and/or DHA at a high content, is effective to hyperlipemia, and has a high nutritive. In the soybean milk product, triglyceride or ethyl ester containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk. The soybean milk product is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk. The invention also provides a food product to be taken in by people as functional foods being effective to hyperlipemia. The triglyceride is a fish oil and preferably a purified fish oil. The fish oil contains EPA and DHA in adjusted amount, more specifically EPA and DHA in total amount of 25% or more. Preferably. the fish oil contains 28% or more of EPA. The soybean milk is soybean milk containing 3% or more of solid part and selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk.
Description
- The present invention relates to a soybean milk product containing EPA at a high content, and more particularly to a soybean milk product, which is effective to hyperlipemia and has a high nutritive value, and a method of producing the soybean milk product.
- Soybean milk is employed not only as materials of Tofu (bean curd), but also as beverages that are directly taken by people as functional foods in recent years. The soybean milk is usually produced as follows. First, soybeans are washed with water for removal of dust and so on. Then, the soybeans are soaked in water at the normal temperature of volume three times as much as the soybeans, and are held in the soaked condition for 5 to 20 hours depending on the season. During such a period, imbibition and germination of the soybeans occurs. Then, the imbibed soybeans are put in a grinding device, such as a mixer and a mortar, and are ground at the normal temperature while water at the normal temperature is added in volume about 5 to 6 times as much as the soybeans. Raw soybean juice (or soybean juice) is thereby produced. After heating the raw soybean juice for about 3 to 15 minutes, it is subjected to a solid-liquid separation process at high temperatures using a solid-liquid separation device, such as a centrifugal separator and a filter press. As a result, soybean milk and bean curd lees are obtained.
- The soybean milk thus produced is provided as Tofu after being added with a coagulant, e.g., bittern, gluconolactone and calcium sulfate, or as beverages after being directly packed in a container and then sealed off. However, beverages containing soybean milk have unpleasant tastes, such as green grass smell and a bitter taste, due to the presence of small amounts of ill-smelling components including 2-hexenal and several kinds of saponins, and those unpleasant tastes have hitherto invited the biggest difficulty in utilization of the soybean milk. Various proposals on lactic bacteria fermentation using lactic bacteria have been made for a taste improvement of the soybean milk. But those proposals for masking the unpleasant odor of a soy bean cancel a body taste and Umami (savory taste) specific to the soy bean. Therefore, the problem of the unpleasant odor and taste specific to the soy bean is not yet overcome at the present.
- It is known that soybean protein has an effect of reducing cholesterol. That fact has increased the number of people eating Tofu recently. However, containers, sauces and spices are required when eating Tofu, and places where people can eat Tofu are limited. On the other hand, when beverages containing soybean milk are packed in containers and sealed off in a portable way, there are no limitations on places for people to drink the packed beverages and people can easily take in the soybean milk as functional foods anywhere.
- Meanwhile, with recent widespread diffusion of preventive medicine knowledge, it has become a prevailing practice for an increasing number of people to preventively take natural origin foods, which have physiological activities, in a healthy or half-healthy condition before they suffer from diseases, for the purpose of keeping themselves healthy. Among those foods, fish such as a horse mackerei, bonito, mackerei and sardine contains a small amount of effective natural compounds, i.e., polyunsaturated fatty acids represented by eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in the form of glycerides. Those natural compounds have lately received keen attention because useful physiological activities, such as a cerebral nerve activation action, a blood cholesterol and lipid lowering effect, and an antiallergic effect, have been found therein one after another in recent years. It has therefore been proposed to not only take those natural compounds as functional foods, but also to mix them in various foods.
- EPA and DHA are typical ones of polyunsaturated fatty acids and are relatively abundantly contained in fat of fish (referred to as a “fish oil” hereinafter), such as fatty meat of a horse mackerei, salmon roe, yellow tail, mackerei, saury, eel, pilchard, rainbow trout, salmon, and saurel. EPA and DHA contained in the fish oil have physiological activity effects, such as a platelet aggregation inhibitory effect, a blood triglyceride lowering effect, and a blood VLDL and LDL cholesterol lowering effect, and hence have preventive and remedial effects for arteriosclerotic diseases. It is also known that depletion of DHA lowers the memory learning ability. While EPA and DHA have, on one side, have many physiological activity effects mentioned above, the fish oil containing EPA and DHA has, on the other side, a peculiar foul odor. Also, those polyunsaturated fatty acids are very easily oxidized because EPA has twenty carbons and five double bonds in a molecule and DHA has twenty-two carbons and six double bonds in a molecule. It is further known that the EPA and DHA generate an unpleasant odor and taste with deterioration of the specific taste.
- Heretofore, various types of soybean milk products have been proposed in consideration of the state of the art described above. As one example of the prior art, Japanese Patent Laid-Open Publication No. 7-255406 discloses a method of producing soy bean processed food enriched with polyunsaturated fat, wherein soybean milk containing polyunsaturated fat is produced by mixing soybean milk and about 1% to about 25% of polyunsaturated fat with respect to the weight of soybean protein in the soybean milk. According to the detailed description in the Publication, “a maximum amount of EPA(DHA)-containing liquid fat uniformly dispersible in 18 liters of soybean milk (about 650 g of protein content) is 160 g (about 25% with respect to the weight of protein in the soybean milk)”, and “if the fat content exceeds about 25%, the fat is not uniformly dispersed and an oil component is separated”.
- As another example of the prior art, Japanese Patent Laid-Open Publication No. 10-42819 discloses “a method of producing a beverage containing DHA-mixed soybean milk, the method comprising the steps of adding and mixing soybean milk and a DHA-containing fish oil at a weight ratio of 1:0.2 to 1, thereby preparing an emulsion of the DHA-containing fish oil, and further diluting the emulsion with the soybean milk”.
- An object of the present invention is to provide a soybean milk product containing fish-oil-originated EPA and/or DHA at a high content, and more particularly to a soybean milk product, which is effective to hyperlipemia and has a high nutritive value, and a method of producing the soybean milk product.
- According to the guideline of an intake specified by JHNA (Japan Health Food & Nutrition Food Association), the required amount of EPA is 750 mg/day in terms of EPA-TG and 1800 mg/day in terms of ethyl ester as a medicine. The above-cited Japanese Patent Laid-Open Publication No. 7-255406 does not disclose the kind of polyunsaturated fat used for producing the soybean milk, the content of EPA and DHA mixed in foods is usually about 25% at maximum. Based on such a value, the EPA content in the soybean milk is calculated as about 0.2%. It is hence cannot be said that the EPA content in the soybean milk satisfies the intake per day sufficiently. Considering, as one practical example, the case where a fish oil having the EPA content of 28% is mixed in the soybean milk having 8% of solid part, a maximum limit in addition of EPA in the prior art is about 280 mg/100 ml on condition that the content of soybean protein in the solid part is about 50%. The present invention is intended to enable the soybean milk to contain EPA in a larger amount than that maximum limit.
- Looking at the condition of patients diagnosed as hyperlipemia, the amount of only triglyceride increases in some ones, the amount of only cholesterol increases in other ones, and the amounts of both triglyceride and cholesterol increase in still other ones. In development of functional foods effective to hyperlipemia, therefore, those functional foods are desirably effective to any types of patients.
- It is known that soybean protein is effective in suppressing a high cholesterol condition and EPA is effective in suppressing a high triglyceride condition. To produce functional foods from soybean protein practically, however, the effectiveness, the ease in use, etc. of the functional foods greatly depend on in what form and amount EPA is mixed because EPA is easily oxidized and has a foul odor, and in what amount the soybean protein is required.
- On an assumption that when people drink soybean milk as functional foods everyday, a maximum limit in amount of the soybean milk capable of being taken in by people per day is about 200 ml, and that the intake of EPA per day is not less than 900 mg in terms of fatty acid glyceride, the present invention is intended to realize a soybean milk product containing soybean protein and EPA at required contents in the soybean milk of not more than 200 ml or not more than 125 ml. Further, the present invention is intended to provide a soybean milk product, to be taken in as functional foods having a superior nutritive value, wherein an appropriate amount of purified fish oil containing EPA is dispersed and dissolved in the soybean milk.
- In addition, the present invention is intended to provide a soybean milk product that is expected to develop physiological activities of DHA contained therein together with EPA.
- According to the present invention, the above object and intensions are achieved by providing a soybean milk product wherein triglyceride or ethyl ester containing 10% or more of EPA is mixed in amount of more than 25% of the soybean protein in the soybean milk.
- To set forth in more detail, the present invention resides in a soybean milk product wherein triglyceride or ethyl ester containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of soybean solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Preferably, the triglyceride is a fish oil. In this case, the present invention resides in a soybean milk product wherein a fish oil containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Preferably, the fish oil contains EPA and/or DHA in adjusted amount. In this case, the present invention resides in a soybean milk product wherein a fish oil containing 10% or more of EPA, or preferably a fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Preferably, the fish oil is a purified fish oil. In this case, the present invention resides in a soybean milk product wherein a purified fish oil containing 10% or more of EPA, or preferably a purified fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Preferably, the fish oil contains EPA and DHA in total amount of 25% or more. In this case, the present invention resides in a soybean milk product wherein a fish oil (preferably purified fish oil) containing 10% or more of EPA and containing EPA and DHA in total amount of 25% or more, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Preferably, the fish oil contains 28% or more of EPA. In this case, the present invention resides in a soybean milk product wherein a fish oil (preferably purified fish oil) containing 28% or more of EPA, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Preferably, the fish oil is a fish oil added with 0.5% or more of tocopherol as an antioxidant. In this case, the present invention resides in a soybean milk product wherein a fish oil containing 10% or more of EPA, preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, each of the fish oils or the purified fish oils being added with 0.5% or more of tocopherol as an antioxidant, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Preferably, the soybean milk product is produced by preparing a soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk. In this case, the present invention resides in a soybean milk product wherein the soybean milk product is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk, the fish oil being a fish oil containing 10% or more of EPA, or a fish oil or a purified fish oil added, as required, with 0.5% or more of tocopherol as an antioxidant, being preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, being more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or being even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, the fish oil being mixed in the soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the soybean milk product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Also, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein triglyceride or ethyl ester containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- In the above food product, preferably, the triglyceride is a fish oil. In this case, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, in which a fish oil containing 10% or more of EPA is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- In the above food product, preferably, the fish oil contains EPA and/or DHA in adjusted amount. In this case, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil containing 10% or more of EPA, or preferably a fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- In the above food product, preferably, the fish oil is a purified fish oil. In this case, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a purified fish oil containing 10% or more of EPA, or preferably a purified fish oil containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- In the above food product, preferably, the fish oil contains EPA and DHA in total amount of 25% or more. In this case, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil (preferably purified fish oil) containing 10% or more of EPA and containing EPA and DHA in total amount of 25% or more, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- In the above food product, preferably, the fish oil contains 28% or more of EPA. In this case, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil (preferably purified fish oil) containing 28% or more of EPA, or preferably a fish oil (purified fish oil) containing EPA and/or DHA in adjusted amount, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- In the above food product, preferably, the fish oil is a fish oil added with 0.5% or more of tocopherol as an antioxidant. In this case, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein a fish oil containing 10% or more of EPA, preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, each of the fish oils or the purified fish oils being added with 0.5% or more of tocopherol as an antioxidant, is mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- In the above food product, preferably, the soybean milk product is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk. In this case, the present invention resides in a food product containing a soybean milk product, the food product being preferably functional food effective to hyperlipemia, wherein the soybean milk is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk, the fish oil being a fish oil containing 10% or more of EPA, or a fish oil or a purified fish oil added, as required, with 0.5% or more of tocopherol as an antioxidant, being preferably a fish oil or a purified fish oil containing EPA and/or DHA in adjusted amount, being more preferably a fish oil or a purified fish oil containing EPA and DHA in total amount of 25% or more, or being even more preferably a fish oil or a purified fish oil containing 28% or more of EPA, the fish oil being mixed in soybean milk in amount of more than 25% of the soybean protein in the soybean milk, the soybean milk being preferably soybean milk containing 3% or more of solid part and, more specifically, being any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk, the food product of the present invention being preferably effective to hyperlipemia and, more specifically, being effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
- Further, the present invention resides in a method of producing a soybean milk product, the method comprising the steps of preparing soybean milk through a series of steps, and then adding and mixing, in the prepared soybean milk, a fish oil containing 10% or more of EPA in amount of more than 25% of the soybean protein in the soybean milk.
- FIG. 1 is a graph showing a change of whole cholesterol over time resulting from a test in Example 6.
- FIG. 2 is a graph showing a change of triglyceride over time resulting from the test in Example 6.
- Soybean milk, preferably soybean milk containing 3% or more of solid part, for use in the present invention may be obtained by any suitable method, and it can be, for example, soybean milk produced by a usual method from soybeans and/or defatted soybeans. Preferably, skin- and albumen-removed soybeans are used in point of providing soybean milk with a better taste. The soybean milk thus produced is provided as a beverage containing the soybean milk as it is, or Tofu after being added with a coagulant, e.g., bittern, gluconolactone and calcium sulfate, or fermented soybean milk (acidified soybean milk) after being subjected to lactic bacteria fermentation. Thus, the soybean milk is any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk.
- Soybean milk can be produced by grinding whole soybeans and/or skin-removed soybeans, which are in a hydrated condition after or without being soaked in water, to obtain soybean juice, and then by removing insoluble fractions from the soybean juice through, e.g., filtration. More specifically, soybean milk is produced as follows. First, whole soybeans, skin-removed soybeans, and/or skin- and albumen-removed soybeans are contacted with warm or hot water at 50 to 100° C. to remove components which are soluble in the warm or hot water. Then, the imbibed soybeans are ground to obtain raw soybean juice (or soybean juice). The soybean juice is immediately introduced to a solid-liquid separation device, such as a centrifugal separator, for quick separation into solid and liquid parts. A filtrate (soybean milk) obtained after removing an insoluble fraction (solid part called bean curd lees) is preferably used as the soybean milk in the present invention. For grinding the imbibed soybeans, an ordinary grinding device, such as a mortar, a mixing machine and a mixer, can be used. The obtained soybean milk may be subjected to heat sterilization at 135 to 150° C. for 1 to 120 seconds, and then cooled.
- In the case of fermenting soybean milk with lactic bacteria, the soybean milk can be produced by a usual method from soybeans and/or defatted soybeans, but may preferably contain 1.0 weight % or less of soluble glucose in a dry material of the soybean milk for the purpose of facilitating control of the lactic bacteria fermentation and providing a product having a fine fresh taste free from unfavorable tastes. Lactic bacteria assimilation saccharides (e.g., oligosaccharides) are not always required, but addition of those saccharides promotes the lactic bacteria fermentation and provides soybean milk having a better taste through the lactic bacteria fermentation. Lactic bacteria for use in the lactic bacteria fermentation are not limited to particular ones, but may be strains usually employed in yogurt, or may be any of combinations of known strains used for improving the taste of the soybean milk.
- For example, known strains of lactic bacteria belonging to such genuses asLactobacillus bulgaricus, Lactobacillus acidophilus, Lactobacillus casei, Streptococcus thermophilus, Streptococcus thermophilus, Streptococcus lactis, and Bifidobacterium, are usable. Those lactic bacteria can be used either alone or a combination of two or more selected from among them.
- A fermentation method can be implemented by adding a bulk starter prepared in advance, or by adding frozen concentrated bacteria or freeze-dry concentrated bacteria directly in the soybean milk. Though depending on the temperature and time of a fermentation process, the amount of added bulk start is, e.g., 0.5 to 15%, and in the case of directly adding lactic bacteria, the amount of the added lactic bacteria is selected so that the onset bacteria density is, e.g., not less than 105/ml.
- The lactic bacteria fermentation can be performed at the fermentation temperature of 20 to 50° C. for 3 to 48 hours and preferably 25 to 45° C. for 4 to 24 hours.
- A fermentation device may be a similar one as that usually employed for producing fermented milk using milk as materials.
- A soybean milk product containing EPA, which is intended by the present invention, is obtained by mixing, in soybean milk which is the filtrate (soybean milk) containing 3% or more of solid part and, or is acidified soybean milk produced from the filtrate through the lactic bacteria fermentation, or is Tofu obtained by curding the filtrate with addition of a coagulant, an EPA-containing purified fish oil in amount of more than 25% of the soybean protein in the soybean milk.
- For increasing the EPA content in a beverage containing the soybean milk, a purified fish oil, which is to be mixed in the filtrate (soybean milk), or acidified soybean milk produced from the filtrate through the lactic bacteria fermentation, or Tofu obtained by curding the filtrate with addition of a coagulant, is preferably concentrated to such an extent that the content of EPA and/or DHA exceeds 25%. The soybean milk produced through the lactic bacteria fermentation, to which the fat has been added, can be provided as fermented soybean milk of soft yogurt type by packing the produced soybean milk, as it is, in a container after the steps of mixing and cooling, or as fermented soybean milk of drink yogurt type by cooling the produced soybean milk after the step of homogenization. Also, various fruit types of soybean milk products can be produced by adding, as required, various flavors, pigments, stabilizers, and fruit preparations.
- Also, the soybean milk produced through the lactic bacteria fermentation, which has been packed in a small container and then fermented, can be provided as lactic-bacteria fermented soybean milk of hard yogurt type by cooling it such a packed condition. In this case, various flavors, pigments, stabilizers, etc. can be freely added to the soybean milk prior to the start of the fermentation.
- The triglyceride for use in the present invention can be given as, e.g., a fish oil and microbe-origin fat, and the ethyl ester for use in the present invention can be given as, e.g., one obtained through ethyl esterification of microbe-origin fat. Origins of the triglyceride and ethyl ester are not matters of problem so long as they can be used as foods.
- The fish oil for use in the present invention is a fish oil containing 10% or more of EPA, preferably a fish oil containing EPA and DHA in total amount of 25% or more, and more preferably a fish oil containing 28% or more of EPA. Also, the fish oil is given as a fish oil or a purified fish containing EPA and/or DHA in adjusted amount. The fish oil may be added with 0.5% or more of tocopherol as an antioxidant.
- The purified fish oil is produced through a first purification process (degumming→refining with alkali→bleaching→filtration) in which a fish oil from raw material fish, such as sardine, is processed to obtain a raw fish oil, and a second purification process (adsorption→distillation→deodorization→addition of antioxidant) in which the raw fish oil is processed into the purified fish oil. By carrying out a wintering process in addition to the usual purification process, it is possible to increase the content of polyunsaturated fatty acids such as EPA and DHA.
- The purified fish oil is mixed in the soybean milk in amount of more than 25% of the soybean protein in the soybean milk so that the guideline of intake of EPA per day, i.e., 750 mg/day, is achieved. On an assumption that when people drink soybean milk as functional foods everyday, a maximum limit in amount of the soybean milk capable of being taken in by people per day is about 200 ml, and that the intake of EPA per day is not less than 900 mg in terms of fatty acid glyceride, the present invention provides a soybean milk product containing soybean protein and EPA at required contents in the soybean milk of not more than 200 ml or not more than 125 ml. Further, the present invention provide a soybean milk product, to be taken in as functional foods having a superior nutritive value, wherein an appropriate amount of purified fish oil containing EPA is dispersed and dissolved in the soybean milk. Although details of the metabolism occurred in the living body are not yet fully clarified, the physiological activities of DHA, which is present in the fish oil along with EPA, can also be expected. From this point of view, a fish oil containing EPA and DHA in total amount of 25% or more is preferably used.
- Production Method
- The soybean milk product is produced by preparing soybean milk through a series of steps, degassing the prepared soybean milk, and then mixing a fish oil in it. In a subsequent emulsifying process, to prevent the soybean milk from taking in oxygen, the emulsification is carried out under an atmosphere replaced by nitrogen, or using a mixing device of the type not allowing the soybean milk to take in air. The emulsification is preferably performed in two stages. Following the first stage of rough emulsification, the second stage of fine emulsification is performed immediately without a time lag. After the emulsification process, the soybean milk containing the fish oil is subjected to heat sterilization and packed in a container with a packing machine.
- The soybean milk product of the present invention implies various types of products made of soybean milk as a main material. The soybean milk includes, for example, raw soybean milk, adjusted soybean milk obtained by processing raw soybean milk, beverages containing soybean milk, and fermented soybean milk obtained through lactic bacteria fermentation.
- A food product containing the soybean milk product of the present invention implies foods that are made of soybean milk so far, foods that can be partly replaced by soybean milk without problems, and foods to which soybean milk can be added without problems. By using the soybean milk product of the present invention in the process of producing those foods, the fish oil containing EPA can be easily mixed in the foods. The foods that can be partly replaced by soybean milk include, for example, milk, yogurt, lactic bacteria drinks, and margarine. The foods to which soybean milk can be added include, for example, breads, cakes, pastes, and sauces.
- Although the fish oil is mixed at a high content in the soybean milk prepared through a series of steps, oxidation resistance can be improved by carrying out the emulsification process which prevents the soybean milk from taking in oxygen. Also, by performing the two stages of emulsification, i.e., rough emulsification and fine emulsification, in succession without a time interval between them, emulsification stability can also be improved. Even in the case of using fermented soybean milk, that emulsification process enables the oil fish to be mixed in the soybean milk after being subjected to the fermentation without problems.
- According to the present invention, functional foods containing EPA in an effective amount can be produced by mixing, in soybean milk containing 3% or more of solid part (including adjusted soybean milk, beverages containing soybean milk, acidified soybean, and Tofu obtained by curding soybean milk), an EPA-containing purified fish oil in amount of more than 25% of the soybean protein in the soybean milk. In practice, when adding a fish oil having an EPA content of 28% to general soybean milk containing 8% or more of solid part, a maximum limit of the added EPA is about 280 mg/100 ml in the prior art. In contrast, the present invention makes it possible to add EPA to the soybean milk in amount higher than such a maximum limit, and to achieve the EPA intake of 750 mg/day that is the guideline of an EPA intake per day specified by JHNA (Japan Health Food & Nutrition Food Association).
- Therefore, the present invention can provide, for example, a beverage effective to hyperlipemia, which contains EPA at a content of 900 mg/125 ml, and a sport drink containing EPA at a content of 900 mg/200 ml.
- As mentioned above, the EPA intake per day recommended by JHNA is 750 mg/day. Additionally, the physiological activities of DHA, which is present in the fish oil along with EPA, can also be expected.
- The present invention will be described below in more detail in connection with Examples. Note that the present invention is not limited to the following Examples.
- Fat used in Examples is a purified fish oil made by Nippon Suisan Kaisha Ltd. and has physical properties shown in Table 1 given below. This purified fish oil is produced through a first purification process (degumming→refining with alkali→bleaching→filtration) in which a fish oil from raw material fish, such as sardine, is processed to obtain a raw fish oil), a wintering process of the raw fish oil, and a second purification process (adsorption→distillation→deodorization→addition of antioxidant) in which the raw fish oil is processed into the purified fish oil.
TABLE 1 Item Standards Analyzing method Properties Pale yellow liquid with Visual observation and no significant sensuality evaluation unpleasant taste or odor Fatty acid composition Gas chromatograph EPA 28.0% or more DHA 12.0% or more Acid value 1.00 or less Fat analysis method Peroxide value 5.0 meq/kg or less Fat analysis method - 10 Kg of a soy bean was soaked in water for 12 hours and ground after adding water in amount seven times as much as the soy bean. After separating bean curd lees, the ground soy bean was heated at 100° C. for deodorization and then subjected to centrifugal separation. By cooling a resulting liquid part, 50 liter of fresh squeezed raw soybean milk (referred to as “soybean milk” hereinafter) was obtained.
- The soybean milk thus obtained was diluted with water so that the soybean milk contained 10% of soybean solid part. A fish oil containing EPA (EPA content of 28%) was mixed in 5 liter of the soybean milk so that the soybean milk contained 1.8% of the fish oil. The mixture was mixed using a homo-mixer and a homegenizer having specifications listed respectively in (1) and (2) below, whereby soybean milk containing EPA (EPA content of 0.5%) was obtained.
- (1) Homo-Mixer (Pre-Emulisification)
- Maker: Tokushu Kika K.K.
- Type: 15H
- No.: 2775
- Head: diameter of 15 cm
- Number of revolutions: 5,000 r.p.m. 5 minutes
- (2) Homegenizer
- Maker: Sanwa Machine K.K.
- No.: 2282
- Capacity: 500 L/h (medium type)
- Pressure: 150 kg two stages (primary 100 kg+secondary 50 kg)
- The soybean milk prepared through the same steps as those in Example 1 was diluted with water so that the soybean milk contained 10% of soybean solid part. A fish oil containing 28% of EPA and 12% of DHA, added with 0.5% of tocopherol, was mixed in 5 liter of the soybean milk. The mixture was mixed using the homo-mixer and the homegenizer, whereby soybean milk containing EPA (EPA content of 0.5%) was obtained.
- A soybean milk product thus produced was packed in a retort pack in a sterility condition, and then left stand at 40° C. for about 3 weeks. As a result of a sensuality test made on the product after that, any fish-origin odor did not occur and any problems were not found.
- A sweetener, a flavor, etc. are first added to water heated to 50-55° C., and the soybean milk was then added to the water. Thereafter, the purified fish oil was added to neutral soybean milk and acidified soybean milk at composition ratio listed in Table 2 given below. Respective resulting products were sealed off and preserved at the room temperature for three months.
TABLE 2 Basic (1) (2) (3) combination (Control (Oil fish (Oil fish Materials ratio % Product) Kg 1.71%) Kg 2.57%) Kg Soybean 42.5 212.5 208.9 207.0 milk or acidified soy bean milk Purified fish 0.0 0.0 8.6 12.9 oil containing EPA · DHA Other 4.2 21.2 20.8 20.6 sweetener, flavor, etc Water 53.3 266.3 261.8 259.5 Total 100.0 500 500 500 - In (2) and (3), the amount of added fish oil was represented for one batch of 500 kg (common preparation liquid+fish oil).
- As a result of examining oxidation stability of the fish oil, satisfactory results for both the products. From the viewpoint of sensuality, it was confirmed that the acidified soybean milk product was superior to the neutral soybean milk product.
- Blood cholesterol and triglyceride lowering effects of the soybean milk product of the present invention were studied by animal tests.
- SD male rats of 4-week age were divided into four groups (control, fish oil, soybean milk and examination groups) each including six rats. The rats in the control group were fed in a free state with feed and water, the feed being prepared by adding 3.6% of an olive oil to basic feed containing 0.5% of cholesterol and 0.25% of cholic acid of sodium. The rats in the fish oil group were fed in a free state with feed and water, the feed being prepared by adding 3.6% of a fish oil, which contained 28% of EPA and 12% of DHA, to the basic feed. The rats in the soybean milk group were fed in a free state with the same feed as that given to the control group and soybean milk. The rats in the examination group were fed in a free state with the same feed as that given to the control group and the soybean milk product of the present invention, which was prepared by adding 1.8% of a fish oil containing 28% of EPA and 12% of DHA to soybean milk. After two weeks, blood was drawn from the anesthetized heart of the rat in each group and measured for whole cholesterol, HDL cholesterol, and trigrylicride in plasma. Measured results are listed in Table 3 given below.
TABLE 3 Plasma HDL Plasma Feed Soybean Plasma chol- tri- intake intake whole esterol glyceride (mean (mean cholesterol (mg/ (mg/ g/day) ml/day) (mg/100 ml) 100 ml) 100 ml) Control 13.8 320.1 ± 42.0 23.8 ± 1.5 72.2 ± 7.8 group Fish oil 13.3 228.8 ± 26.6 28.4 ± 2.3 45.1 ± 3.9 group Soybean 13.7 26.8 306.7 ± 32.9 23.5 ± 3.0 67.9 ± 5.7 milk group Examina- 13.6 26.5 211.3 ± 25.0 30.3 ± 2.9 42.2 ± 4.3 tion group - As shown in Table 3, it was confirmed that the values of whole cholesterol and trigrylicride in plasma were apparently reduced in the examination group as compared with the control group, and that both the values were slightly lower in the examination than in the fish oil group.
- A pre-test was conducted on the blood triglyceride lowering effect of the soybean milk product of the present invention based on a human test.
- <Production Process>
- The production process in this Example is featured in performing a pre-emulsification step prior to the emulsification step for the purpose of improving a level of emulsification and providing the product superior in emulsification stability. The production process comprises the steps of preparation of soybean milk→degassing→pre-emulsification→emulsification→sterilization→packing. The pre-emulsification was first performed to such an extent that the grain size of 60 to 70 μm was obtained, and the main emulsification was then performed to such an extent that the grain size of 1 to 5 μm was obtained. (The term “grain size” mans the mean grain size measured using SALD-200VER made by Shimazu Seisakusho K.K.)
- Note that by using an EPA-containing fish oil purified with the high-level purifying technique, a product being more superior in both preservability and taste can be obtained.
- 1) Details of Test
- (1) Subjects: persons nearly suffering hyperlipemia (a man “S” at twenties and a man “F” at fourties)
- (2) Period: 8 weeks (2 months)
- (3) Inake: 600 mg/200 ml of EPA (in soybean milk) per day (no limitations on intake time)
- (4) Remarks: no limitations on living style such as dietary restriction
- 2) Results
- Table 4: triglyceride value (mg/dl) for “S” and “F”
TABLE 4 Triglyceride Value (mg/dl) 0 week 2 weeks 4 weeks 6 weeks 8 weeks “S” 249 203 133 164 115 “F” 180 108 148 181 140 - <Review>
- As a result of the pre-test, the triglyceride value was improved for both “S” and “F”, who were nearly suffering hyperlipemia, just by taking in 600 mg/200 ml of EPA (in soybean milk) per day for 8 weeks (2 months) with neither limitations on intake time nor limitations on living style such as dietary restriction.
- Clinical Test on Healthy Volunteers
- <Sample Used>
- A sample used was fermented soybean milk (one 125-ml bottle mixed with 900 mg of EPA and 350 mg of DHA) in which a purified fish oil containing eicosapentaenoic acid and docosahexaenoic acid (referred to as “EPA. DHA” hereinafter). The nutrient composition and material combination ratio of the used sample are listed in Tables 5 and 6 given below. The fermented soybean milk was a commercialized one made by Fuji Oil K.K., and the purified fish oil containing EPA•DHA was a commercialized one made by Nippon Suisan KAISHA LTD.
- <Subjects>
- Eleven volunteers (mean age of 41.9±8.5, male) were selected who had serum triglycride values of not less than 150 mg/dl and serum whole cholesterol values of not less than 200 mg/dl, and were living in healthy conditions.
- <Test Method>
- Each of the volunteers continued drinking one bottle of a beverage mixed with the purified fish oil containing EPA•DHA (one 125-ml bottle mixed with 900 mg of EPA and 350 mg of DHA) per day for three months. After about 12 weeks from starting to take in the beverage, a change of serum fat was measured.
- <Results>
- The serum whole cholesterol value was reduced from 231±31 mg/dl (mean±standard deviation, this similarly applied to values given below) at the time of starting to take in the beverage down to 211±36.4 mg/dl, i.e., 8.7%, after 12 weeks (FIG. 1). Also, the serum triglycride value was reduced from 236.8±88.2 mg/dl at the time of starting to take in the beverage down to 156.8±56.4 mg/dl, i.e., 33.8%, after 12 weeks (FIG. 2). During the test period, neither problematic side effects nor drop-out examples occurred. It was hence confirmed from those results that the fermented soybean milk containing EPA are foods which people are able to drink continuously and which are useful for health care of persons having relatively high serum fat values.
TABLE 5 Nutrient Composition of Tested Food Product Analysis item Unit Water g 108.3 Protein g 2.0 Fat g 5.1 Ash g 0.1 Carbohydrate g 0.1 Energy kcal 79.3 Sodium mg 21.0 Eicosapentaenoic acid (EPA) g 0.84 Docosahexaenoic acid (DHA) g 0.35 -
TABLE 6 Combination Ratio of Materials Materials Composition ratio Fermented soybean milk 42.4% Purified fish oil containing EPA · DHA 2.6% Other sweetener, flavor, etc. 4.4% Water 50.5% 100.0% - According to the present invention, functional foods can be provided which enable people to take in soybean protein and EPA DHA in respective required amounts when the people drink or eat the soybean milk product of the present invention everyday.
- Also, according to the present invention, a soybean milk product containing EPA•DHA can be provided which does not cause a fish odor originating from a fish oil uses as materials, which is superior in taste, smell and texture, which shows good preservability of EPA•DHA, which and enables people to take in EPA•DHA together with soybean milk as a good protein source.
- Further, according to the present invention, a stable soybean milk product containing EPA•DHA at high contents can be provided with the production process in which, to prevent the soybean milk from taking in oxygen during the production process, the emulsification is carried out under an atmosphere replaced by nitrogen, or using a mixing device of the type not allowing the soybean milk to take in air, and in which the second stage of fine emulsification is performed immediately after the first stage of rough emulsification.
Claims (15)
1. A soybean milk product containing triglyceride or ethyl ester, wherein the triglyceride or ethyl ester contains 10% or more of EPA, and the amount of triglyceride or ethyl ester is more than 25% of the amount of the soybean protein in the soybean milk.
2. A soybean milk product according to claim 1 , wherein the triglyceride is a fish oil.
3. A soybean milk product according to claim 2 , wherein the contents of EPA and/or DHA in the fish oil is adjusted.
4. A soybean milk product according to claim 2 or 3, wherein the fish oil is a purified fish oil.
5. A soybean milk product according to any one of claims 2, 3 and 4, wherein the fish oil contains 25% or more of total amount of EPA and DHA.
6. A soybean milk product according to any one of claims 2 to 5 , wherein the fish oil contains 28% or more of EPA.
7. A soybean milk product according to any one of claims 1 to 6 , wherein the soybean milk is soybean milk containing 3% or more of solid part.
8. A soybean milk product according to any one of claims 1 to 7 , wherein the soybean milk is any one selected from among adjusted soybean milk, a beverage containing soybean milk, acidified soybean milk, and Tofu obtained by curding soybean milk.
9. A soybean milk product according to any one of claims 2 to 8 , wherein the fish oil is a fish oil added with 0.5% or more of tocopherol as an antioxidant.
10. A soybean milk product according to any one of claims 2 to 9 , wherein the soybean milk product is produced by preparing soybean milk through a series of steps, and then adding and mixing a fish oil in the prepared soybean milk.
11. A soybean milk product according to any one of claims 1 to 10 , wherein the soybean milk product is effective to hyperlipemia.
12. A soybean milk product according to claim 11 , wherein the soybean milk product is effective to any types of hyperlipemia in which the amount of only triglyceride increases, the amount of only cholesterol increases, and the amounts of both triglyceride and cholesterol increase.
13. A food product containing a soybean milk product according to any one of claims 1 to 12 .
14. A food product according to claim 13 , wherein the food product is functional food effective to hyperlipemia.
15. A method of producing a soybean milk product, comprising the steps of preparing soybean milk through a series of steps, and the step of mixing a fish oil into the prepared soybean milk, wherein the fish oil contains 10% or more of EPA and the amount of the fish oil is more than 25% of the soybean protein in the soybean milk.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-344863 | 2000-11-13 | ||
JP2000344863 | 2000-11-13 | ||
PCT/JP2001/009878 WO2002037985A1 (en) | 2000-11-13 | 2001-11-12 | Soybean milks containing epa at high concentration and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040052925A1 true US20040052925A1 (en) | 2004-03-18 |
Family
ID=18818998
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/416,019 Expired - Fee Related US7651720B2 (en) | 2000-11-13 | 2001-11-12 | EPA and/or DHA-containing acidic milks |
US10/416,020 Abandoned US20040052925A1 (en) | 2000-11-13 | 2001-11-12 | Soybean milks containing epa at high concentration and process for producing the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/416,019 Expired - Fee Related US7651720B2 (en) | 2000-11-13 | 2001-11-12 | EPA and/or DHA-containing acidic milks |
Country Status (13)
Country | Link |
---|---|
US (2) | US7651720B2 (en) |
EP (2) | EP1340429A4 (en) |
JP (3) | JP4738714B2 (en) |
KR (3) | KR20080064882A (en) |
CN (2) | CN100405919C (en) |
AT (1) | ATE410066T1 (en) |
CA (2) | CA2426853A1 (en) |
DE (1) | DE60136093D1 (en) |
DK (1) | DK1340427T3 (en) |
ES (1) | ES2312482T3 (en) |
PT (1) | PT1340427E (en) |
TW (2) | TWI274552B (en) |
WO (2) | WO2002037985A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080286414A1 (en) * | 2005-06-27 | 2008-11-20 | Pharmalogica As | Drink Comprising a Combination of Fish Oil and Probiotics |
US20100047389A1 (en) * | 2006-10-31 | 2010-02-25 | Fuji Oil Company, Limited | Food or beverage containing highly unsaturated fatty acid,and process for production thereof |
US20110072984A1 (en) * | 2009-09-30 | 2011-03-31 | Chen Cheng-Feng | Automatic bean curd maker |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2426853A1 (en) * | 2000-11-13 | 2003-04-24 | Nippon Suisan Kaisha, Ltd. | Soybean milks containing epa at high concentration and process for producing the same |
DE20220081U1 (en) * | 2002-12-23 | 2003-04-30 | Unilever Nv | Edible emulsion that contains highly unsaturated fats |
IL155136A0 (en) * | 2003-02-10 | 2003-10-31 | Enzymotec Ltd | A composition for reducing blood cholesterol and triglycerides |
JP2005075822A (en) * | 2003-09-04 | 2005-03-24 | Nof Corp | Autoimmune disease prophylactic for older person and igm antibody production inhibitor |
JP4317801B2 (en) * | 2004-08-10 | 2009-08-19 | 学校法人武庫川学院 | Food composition for improving lipid metabolism and food containing the same |
ES2391305T3 (en) | 2006-04-12 | 2012-11-23 | Unilever N.V. | Oral composition comprising a polyunsaturated fatty acid and salicylic acid to obtain an anti-inflammatory effect on the skin |
MX2008012998A (en) | 2006-04-12 | 2008-10-17 | Unilever Nv | Oral composition with an antiageing effect on the skin. |
US20070280998A1 (en) * | 2006-06-02 | 2007-12-06 | Larry Milligan | Dairy product |
US9185922B2 (en) | 2006-06-02 | 2015-11-17 | University Of Guelph | Dairy product |
ITBO20070651A1 (en) * | 2007-09-25 | 2009-03-26 | Famiglia Chiari S R L | PROCEDURE FOR REALIZING A CASE PRODUCT AND CASE PRODUCT. |
US20110177224A1 (en) * | 2008-03-03 | 2011-07-21 | Daniel Perlman | Stabilization of omega-3 fatty acids in oil-water emulsions |
CN101406218B (en) * | 2008-11-13 | 2011-07-20 | 内蒙古伊利实业集团股份有限公司 | Liquid dairy food containing fish oil and method for producing the same |
CN103429100B (en) | 2010-09-07 | 2015-09-02 | 帝斯曼营养品股份公司 | Edible emulsion |
CN103221041B (en) * | 2010-11-19 | 2016-08-03 | 日本水产株式会社 | For corneal epithelium pathological changes and/or the therapeutic agent of conjunctival epithelium pathological changes or preventive |
US8551551B2 (en) | 2012-01-06 | 2013-10-08 | Perlman Consulting, Llc | Stabilization of omega-3 fatty acids in saturated fat microparticles having low linoleic acid content |
CN102696761A (en) * | 2012-06-19 | 2012-10-03 | 黑龙江飞鹤乳业有限公司 | Method for preparing docosahexaenoic acid (DHA) and eicosatetraenoic acid (ARA) emulsion |
JP2016067340A (en) | 2014-10-02 | 2016-05-09 | 日健化学株式会社 | Food and drink |
CN105580906A (en) * | 2014-10-24 | 2016-05-18 | 内蒙古伊利实业集团股份有限公司 | Soybean milk, soybean milk beverage and manufacturing methods thereof |
CN107318992A (en) * | 2017-09-05 | 2017-11-07 | 史笑寒 | A kind of soya-bean milk slurries of the DHA containing high concentration and preparation method and application |
JP6733837B2 (en) * | 2018-01-25 | 2020-08-05 | 不二製油株式会社 | Soymilk drink containing highly unsaturated fatty acids |
JP7135375B2 (en) * | 2018-03-28 | 2022-09-13 | 不二製油株式会社 | Oil composition containing long-chain polyunsaturated fatty acid |
FR3114941B1 (en) * | 2020-10-12 | 2024-03-22 | Algama | Process for obtaining a milk substitute drink based on microalgae by heat treatment |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4794017A (en) * | 1986-09-19 | 1988-12-27 | Asama Chemical Co., Ltd. | Soybean processed food |
US5976606A (en) * | 1996-07-30 | 1999-11-02 | Janiftec, Inc. | Process for producing DHA-containing tofu or soybean milk drink, or dry powder thereof |
US6313167B1 (en) * | 1997-06-16 | 2001-11-06 | Nippon Suisan Kaisha Ltd. | Composition having capability of removing risk factor during exercise |
US20040131727A1 (en) * | 2000-11-13 | 2004-07-08 | Shuji Nakajima | Epa and/or dha-containing acidic milks |
US6905850B2 (en) * | 2000-07-13 | 2005-06-14 | Nippon Suisan Kaisha, Ltd. | Process for the production of glycerides with lipases |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3937843A (en) * | 1972-12-04 | 1976-02-10 | Laboratorios Del Dr. Esteve Sa | Bean-odor-free soy bean product and its production |
JPS5967241A (en) * | 1982-10-08 | 1984-04-16 | Kureha Chem Ind Co Ltd | Method for concentrating eicosapentaenoic acid in fish oil |
JPS6023493A (en) * | 1983-07-18 | 1985-02-06 | 高尾 正保 | Purified fish oil and manufacture |
JPS6034156A (en) * | 1983-08-08 | 1985-02-21 | Hayashibara Biochem Lab Inc | Eicosapentaenoic acid clathrate compound and food and drink containing the same |
JPS60160840A (en) | 1983-12-28 | 1985-08-22 | Miyoshi Oil & Fat Co Ltd | Health food |
JPS6121048A (en) * | 1984-07-10 | 1986-01-29 | Mitsubishi Chem Ind Ltd | Production of acidic soybean milk beverage |
JPS61231958A (en) * | 1985-04-09 | 1986-10-16 | Kazuo Hara | Production of food |
JPS63216435A (en) * | 1987-03-06 | 1988-09-08 | Asahi Denka Kogyo Kk | Production of ice creams |
US4913921A (en) * | 1987-09-11 | 1990-04-03 | General Mills, Inc. | Food products containing fish oils stabilized with fructose |
JP3128635B2 (en) | 1992-09-08 | 2001-01-29 | 雪印乳業株式会社 | Method for producing fermented milk containing polyunsaturated fatty acids |
JPH07107907A (en) * | 1993-10-15 | 1995-04-25 | Kiteii:Kk | Production of fat and oil emulsion |
KR100343664B1 (en) * | 1993-12-20 | 2002-11-27 | 산에이겐 에후.에후. 아이. 가부시키가이샤 | Stable emulsified compositions and foods containing the same |
CN1108891A (en) * | 1994-03-21 | 1995-09-27 | 中国科学院大连化学物理研究所 | Enhanced milk containing polyunsaturated fatty acid |
JPH07255406A (en) | 1994-03-24 | 1995-10-09 | Hisatomi Shokuhin Kogyo Kk | Production of highly unsaturated fat and oil-enriched soybean processed food |
JPH0889167A (en) * | 1994-09-27 | 1996-04-09 | Nippon Oil & Fats Co Ltd | Production of polyvalent unsaturated fatty acid-containing fermented milk |
NL9401644A (en) | 1994-10-06 | 1996-05-01 | Friesland Brands Bv | Food for pregnant and lactating women |
EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
JP2780154B2 (en) * | 1995-02-17 | 1998-07-30 | 株式会社ヤクルト本社 | Yogurt |
CN1135290A (en) * | 1995-05-11 | 1996-11-13 | 长沙市牛奶公司 | Nutrious milk powder |
JPH08308521A (en) | 1995-05-22 | 1996-11-26 | Kanagawa Kagaku Kenkyusho:Kk | Tofu containing docosahexaenoic acid and its production |
JPH08322464A (en) | 1995-05-26 | 1996-12-10 | Yakult Honsha Co Ltd | Yogurt containing bifidobacterium cell body and its production |
DK0862369T4 (en) * | 1995-11-24 | 2009-12-14 | Unilever Nv | Composition based on fish oil |
JP3567960B2 (en) | 1996-01-23 | 2004-09-22 | 株式会社ベルリッチ | Odorless, stable oil and emulsion |
TW360501B (en) * | 1996-06-27 | 1999-06-11 | Nestle Sa | Dietetically balanced milk product |
JPH10146167A (en) * | 1996-11-15 | 1998-06-02 | Toyo Yakushiyoku Kogyo Kk | Healthy food |
JP3554647B2 (en) | 1997-02-25 | 2004-08-18 | 太陽化学株式会社 | Oil composition |
US6194379B1 (en) * | 1998-05-01 | 2001-02-27 | Abbott Laboratories | Elemental enteral formula |
EP0956779A1 (en) * | 1998-05-11 | 1999-11-17 | Vesifact Ag | Foods containing water-insoluble compounds |
NZ500703A (en) * | 1998-11-04 | 2001-06-29 | F | Preparation of food-grade marine edible oils by treatment with silica, vacuum steam deodorisation and addition of a herb extract |
JP2002204656A (en) * | 2001-01-10 | 2002-07-23 | Yakult Honsha Co Ltd | Fermented milk beverage and method for producing the same |
-
2001
- 2001-11-12 CA CA002426853A patent/CA2426853A1/en not_active Abandoned
- 2001-11-12 WO PCT/JP2001/009878 patent/WO2002037985A1/en not_active Application Discontinuation
- 2001-11-12 KR KR1020087012189A patent/KR20080064882A/en not_active Application Discontinuation
- 2001-11-12 AT AT01982759T patent/ATE410066T1/en not_active IP Right Cessation
- 2001-11-12 US US10/416,019 patent/US7651720B2/en not_active Expired - Fee Related
- 2001-11-12 ES ES01982759T patent/ES2312482T3/en not_active Expired - Lifetime
- 2001-11-12 DE DE60136093T patent/DE60136093D1/en not_active Expired - Lifetime
- 2001-11-12 WO PCT/JP2001/009879 patent/WO2002037976A1/en active Application Filing
- 2001-11-12 KR KR10-2003-7006303A patent/KR20030048466A/en active Application Filing
- 2001-11-12 KR KR10-2003-7005887A patent/KR20030048449A/en active Search and Examination
- 2001-11-12 DK DK01982759T patent/DK1340427T3/en active
- 2001-11-12 CN CNB018187862A patent/CN100405919C/en not_active Expired - Fee Related
- 2001-11-12 EP EP01982758A patent/EP1340429A4/en not_active Withdrawn
- 2001-11-12 CN CNB01818684XA patent/CN1289001C/en not_active Expired - Fee Related
- 2001-11-12 EP EP01982759A patent/EP1340427B1/en not_active Expired - Lifetime
- 2001-11-12 CA CA2426854A patent/CA2426854C/en not_active Expired - Fee Related
- 2001-11-12 US US10/416,020 patent/US20040052925A1/en not_active Abandoned
- 2001-11-12 JP JP2002540584A patent/JP4738714B2/en not_active Expired - Fee Related
- 2001-11-12 JP JP2002540576A patent/JP4202130B2/en not_active Expired - Fee Related
- 2001-11-12 PT PT01982759T patent/PT1340427E/en unknown
- 2001-11-13 TW TW090128102A patent/TWI274552B/en not_active IP Right Cessation
- 2001-11-13 TW TW090128101A patent/TWI265785B/en not_active IP Right Cessation
-
2008
- 2008-03-10 JP JP2008059537A patent/JP2008201785A/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4794017A (en) * | 1986-09-19 | 1988-12-27 | Asama Chemical Co., Ltd. | Soybean processed food |
US5976606A (en) * | 1996-07-30 | 1999-11-02 | Janiftec, Inc. | Process for producing DHA-containing tofu or soybean milk drink, or dry powder thereof |
US6313167B1 (en) * | 1997-06-16 | 2001-11-06 | Nippon Suisan Kaisha Ltd. | Composition having capability of removing risk factor during exercise |
US6905850B2 (en) * | 2000-07-13 | 2005-06-14 | Nippon Suisan Kaisha, Ltd. | Process for the production of glycerides with lipases |
US20040131727A1 (en) * | 2000-11-13 | 2004-07-08 | Shuji Nakajima | Epa and/or dha-containing acidic milks |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080286414A1 (en) * | 2005-06-27 | 2008-11-20 | Pharmalogica As | Drink Comprising a Combination of Fish Oil and Probiotics |
US20100047389A1 (en) * | 2006-10-31 | 2010-02-25 | Fuji Oil Company, Limited | Food or beverage containing highly unsaturated fatty acid,and process for production thereof |
US20110072984A1 (en) * | 2009-09-30 | 2011-03-31 | Chen Cheng-Feng | Automatic bean curd maker |
Also Published As
Publication number | Publication date |
---|---|
JP4202130B2 (en) | 2008-12-24 |
KR20030048466A (en) | 2003-06-19 |
CN1289001C (en) | 2006-12-13 |
CA2426854C (en) | 2010-08-31 |
CN1533247A (en) | 2004-09-29 |
CA2426853A1 (en) | 2003-04-24 |
KR20080064882A (en) | 2008-07-09 |
EP1340429A4 (en) | 2004-10-27 |
EP1340427B1 (en) | 2008-10-08 |
PT1340427E (en) | 2008-11-06 |
JP4738714B2 (en) | 2011-08-03 |
US20040131727A1 (en) | 2004-07-08 |
TWI265785B (en) | 2006-11-11 |
DK1340427T3 (en) | 2009-01-19 |
KR20030048449A (en) | 2003-06-19 |
ATE410066T1 (en) | 2008-10-15 |
ES2312482T3 (en) | 2009-03-01 |
CA2426854A1 (en) | 2003-04-24 |
EP1340429A1 (en) | 2003-09-03 |
EP1340427A1 (en) | 2003-09-03 |
WO2002037985A1 (en) | 2002-05-16 |
WO2002037976A1 (en) | 2002-05-16 |
JPWO2002037976A1 (en) | 2004-03-11 |
DE60136093D1 (en) | 2008-11-20 |
JPWO2002037985A1 (en) | 2004-03-11 |
EP1340427A4 (en) | 2004-10-27 |
TWI274552B (en) | 2007-03-01 |
US7651720B2 (en) | 2010-01-26 |
CN1633239A (en) | 2005-06-29 |
JP2008201785A (en) | 2008-09-04 |
CN100405919C (en) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040052925A1 (en) | Soybean milks containing epa at high concentration and process for producing the same | |
US7824727B2 (en) | Method of making a liquid egg composition with fish oil | |
EP2067406B1 (en) | Ubiquinol-enriched fat-containing dairy products | |
EP2037757B1 (en) | Feed product for dairy cows and method of obtaining a dairy product | |
JP6773562B2 (en) | Sphingolipid absorption promoter | |
US9185922B2 (en) | Dairy product | |
RU2243672C2 (en) | Method for producing of prophylactic lactic-acid bifidus activating product | |
JP2022521345A (en) | Compositions containing choline and omega-3 fatty acids for fortifying food products | |
RU2155489C1 (en) | Method of preparing curative-prophylactic fermented milk bifido-containing product | |
JP7271582B2 (en) | Low-calorie soymilk with reduced bean odor | |
RU2139664C1 (en) | Method for obtaining milk-based food product | |
KR100348461B1 (en) | The soybean paste, cantained a lactobacillus and mainly stuffed with soybean powder, and the manufacturing method of the above paste | |
KR20230081961A (en) | Food composition comprising fermented rice germ lactic acid bacteria | |
JPH0269157A (en) | Functional food and production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NIPPON SUISAN KAISHA, LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAKAJIMA, SHUJI;YAMAGISHI, YOKO;HATA, KAZUHIKO;REEL/FRAME:014563/0107;SIGNING DATES FROM 20030506 TO 20030513 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |